miércoles, 11 de marzo de 2020

Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study | NIH: National Institute of Allergy and Infectious Diseases

Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study | NIH: National Institute of Allergy and Infectious Diseases

NIAID Logo

Illustration of a virus delivering genetic material into a cell

Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study

New Strategy Could Be Applied to Other Infectious Diseases

March 9, 2020
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)